Shasun Pharmaceuticals disclosed a steep drop in consolidated net profit for the quarter ended March 2014. During the quarter, the profit of the company declined 21.57% to Rs 104 million from Rs 132.60 million in the same quarter previous year.
Net sales for the quarter declined 86.85% to Rs 363.26 million, compared with Rs 2,763.30 million for the prior year period.
Earnings per share for the quarter stood at Rs 1.84, registering 23.33% decline over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Mar - 14 | Mar - 13 | %Change |
| Net Sales | 363.26 | 2,763.30 | (86.85) |
| Net Profit | 104.00 | 132.60 | (21.57) |
| Basic EPS | 1.84 | 2.40 | (23.33) |
Shares of the company declined Rs 1.9, or 1.35%, to settle at Rs 139. The total volume of shares traded was 37,262 at the BSE (Friday).
